Iron Guide · Safety

Does an iron infusion raise the risk of infection?

Iron feeds bacteria, the saying goes, so an infusion ought to encourage infections. The idea sounds logical. What the large studies really show, and why an acute infection is still a good reason to wait.

Evidence reassuring Iron and the immune system Acute infection Evidence-based

It is one of the most persistent arguments against the iron infusion: iron is said to be food for bacteria, so additional iron must prepare the ground for infections. The thought is not pulled out of thin air. It describes a real biological mechanism. The only question is whether this theory also shows up in the numbers of large studies, or whether it holds in one place and not in another.

This article takes the hypothesis seriously instead of brushing it aside. We first look at why it is plausible at all. Then we place the data next to it. And in the end we arrive at a distinction that explains almost everything: it depends not only on whether iron is given, but on when.

My starting point

The worry that iron could feed pathogens is not an esoteric fear, but a real mechanism from immune biology. That is exactly why it deserves an honest answer rather than a reassuring one. The short version: in a stable state, the evidence is largely reassuring. During an acute infection, caution applies. Together, the two do not add up to an either-or, but to a question of the right timing.

Why the concern makes biological sense

Many people who hear this hypothesis for the first time pause briefly and think: that actually sounds plausible. That feeling is justified. Behind the concern lies a piece of well-researched biology, not a myth.

Almost all living things need iron, including pathogens. Bacteria require it for their metabolism and their reproduction. The human body knows this, in a sense, and uses it as a defence strategy. As soon as an infection begins, it deliberately lowers the freely available iron in the blood. Experts call this nutritional immunity, that is, defence through nutrient deprivation. The body starves out the intruders.

Mechanism review Iron and innate defence

Who and what: A detailed review describes how the immune system redistributes iron specifically during an infection to make access harder for pathogens, a principle known as nutritional immunity.

What it describes: In an infection with bacteria outside the cells, the hormone hepcidin rises and holds iron back in the stores, so that less iron circulates in the blood. This deprives pathogens of the nutrient.

What this means for you: The body has a built-in protection that keeps iron scarce during an infection. This very protection is the reason not to place an infusion in the middle of an acute infection.

Nairz M, Weiss G. Iron and innate antimicrobial immunity: Depriving the pathogen, defending the host. J Trace Elem Med Biol 2018;48:118-133. [Mechanism review] DOI: 10.1016/j.jtemb.2018.03.007

The central tool of this strategy is a hormone called hepcidin. It rises with inflammation and ensures that iron stays in the stores rather than reaching the blood. From the point of view of defence, this is clever. From the point of view of someone suffering from iron deficiency, it is sometimes a nuisance, because the same mechanism also blocks the uptake of iron from tablets in chronic inflammation. How closely iron and the immune system are interwoven has been known for a long time.

Mechanism review Iron in innate immunity

Who and what: A widely cited review summarises how the body holds iron back during an infection to starve out intruders, and describes hepcidin as the central switch of this response.

What this means for you: That the body downregulates iron during an infection is well-established basic biology. The legitimate question is whether a controlled infusion in a stable state really undermines this protection.

Ganz T. Iron in innate immunity: starve the invaders. Curr Opin Immunol. 2009;21(1):63-67. [Mechanism review] DOI: 10.1016/j.coi.2009.01.011

Up to this point the hypothesis stands on firm ground. If pathogens need iron and the body withholds it from them, then additional iron could in theory undermine this protection. In theory. Whether this happens in reality cannot be decided at a desk, but only from the data of people who have received intravenous iron.

What the large studies actually show

When a plausible theory meets real data, it gets interesting. Because this is exactly where the picture becomes calmer than the theory might fear, without becoming entirely smooth. It is worth placing three large analyses side by side, because together they paint a nuanced picture.

The most comprehensive review is at the same time the most important, because it is the only one to find a slight signal. It summarised 154 randomised trials with almost 33,000 participants and looked specifically at infections.

Meta-analysis · 154 RCT · n=32,920 Infection risk of IV iron

Who and what: A systematic review and meta-analysis evaluated 154 randomised trials with about 32,920 participants and compared intravenous iron with oral iron or no iron, with a focus on infections.

What they observed: With intravenous iron, a slightly raised relative infection risk of around 1.17 appeared, so roughly 17 percent above the comparison group, with moderate certainty of the evidence. This had no recognisable effect on mortality or length of hospital stay. At the same time the haemoglobin value rose and the need for blood transfusions fell.

What this means for you: There is a small, real signal for somewhat more infections, but no indication that this leads to more people dying or staying longer in hospital. This puts the size of the concern into perspective without dissolving it entirely.

Shah AA, Donovan K, Seeley C, et al. Risk of infection associated with administration of intravenous iron: a systematic review and meta-analysis. JAMA Netw Open. 2021;4(11):e2133935. [Meta-analysis, 154 RCT, n=32,920] DOI: 10.1001/jamanetworkopen.2021.33935

This result is the most honest part of the whole topic, which is why it is deliberately not hidden away at the margin. Yes, there is a signal. No, it is not large, and it does not translate into harder endpoints such as mortality. That is exactly how it should be read: as a hint to be careful and situation-dependent, not as proof that the infusion is dangerous.

An older, also large analysis points in a similar direction and makes the range visible. It was originally aimed at avoiding blood transfusions.

Meta-analysis · 72 RCT · n=10,605 Benefit and infection signal

Who and what: A meta-analysis of 72 randomised trials with over 10,600 participants examined whether intravenous iron lowers the need for blood transfusions, and recorded infections as well.

What they observed: Intravenous iron clearly lowered the need for transfusion and raised the haemoglobin value. At the same time, a raised relative infection risk of around 1.33 was found. The authors therefore described the benefit as accompanied by a possible infection risk.

What this means for you: Here too a clear benefit stands against an infection signal. The trade-off depends on the situation and the goal with which the iron is given.

Litton E, Xiao J, Ho KM. Safety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: systematic review and meta-analysis of randomised clinical trials. BMJ. 2013;347:f4822. [Meta-analysis, 72 RCT, n=10,605] DOI: 10.1136/bmj.f4822

Anyone now thinking the signal is fairly clear may be helped to put it into context by a third, very large analysis. It comes from safety research on iron preparations in general and reaches a more reassuring conclusion.

Meta-analysis · 103 RCT · n=10,390 Safety of IV iron

Who and what: A systematic review and meta-analysis summarised 103 randomised trials with about 10,400 recipients of intravenous iron and examined safety overall.

What they observed: There was no increased risk of serious adverse events compared with the control groups. Infections also did not occur more often in this analysis.

What this means for you: The analyses do not agree in every detail. That is normal when different studies, situations and definitions of infection come together. This very spread argues against a large, sweeping effect.

Avni T, Bieber A, Grossman A, et al. The safety of intravenous iron preparations: systematic review and meta-analysis. Mayo Clin Proc. 2015;90(1):12-23. [Meta-analysis, 103 RCT, n=10,390] DOI: 10.1016/j.mayocp.2014.10.007

Why do these works seem to contradict each other? One important reason is that infection is defined very differently across studies, from a mild respiratory infection to severe sepsis. Where the bar is set influences the result. The review with the slight signal itself points out that well-designed studies with a uniform definition of infection are needed to understand the balance between risk and benefit more precisely. This humility is part of the topic.

The reframe

The question does iron feed the bugs has no simple yes-or-no answer, because it leaves out one condition: what state the body is in. In a stable person with a genuine deficiency, the data show at most a small infection signal and no effect on mortality. In the middle of an acute infection, the situation is different. The right translation of the hypothesis is therefore not iron is dangerous, but iron at the wrong time is unfavourable.

The decisive difference: stable or acutely infected

Now the two strands come together. Biology says that the body holds iron back during an infection. The large studies say that a planned infusion in stable people carries, on average, no great infection risk. The two fit together as soon as you factor in the timing.

During an acute infection that needs treatment, the body's own programme of iron lockdown runs at full speed. Adding iron through the vein in this phase works against this protection. This is the understandable core behind the recommendation to let an acute infection clear first. It is not that iron is generally harmful, but that the timing in the middle of an infection is the most unfavourable imaginable.

Acute infection as a reason for caution An acute, feverish infection or one that needs treatment is considered a reason to postpone a planned iron infusion. There are two reasons for this. First, the body holds iron back in this phase anyway, so a dose would run against this protection. Second, the iron values in the blood are altered during an infection and hard to interpret, so an indication can hardly be set cleanly. Once it has cleared, both can be judged more reliably.

This caution is not a distrust of the treatment. It is part of what a properly performed infusion involves. A careful assessment before the dose asks not only about the iron value, but also whether an infection is present right now. Anyone who proceeds this way takes the wind out of the sails of the iron-feeds-the-bugs hypothesis exactly where it could most plausibly apply.

One patient group is particularly instructive here, because it receives iron through the vein regularly over years: people on dialysis. If frequent intravenous iron doses strongly encouraged infections, this is where you would most likely see it.

Review · RCT and observational · n>130,000 Dialysis and infection

Who and what: A systematic review summarised randomised and observational studies in dialysis patients, over 130,000 people in total, and compared higher-dose with lower-dose intravenous iron.

What they observed: Higher-dose intravenous iron was not clearly associated with a higher infection risk. In the randomised trials the relative risk was close to one, and in the observational data no clearly increased risk appeared. Mortality, cardiovascular events and hospital stays were not increased either.

What this means for you: Even with regular, long-term dosing the infection signal stays limited, as long as the indication and dose are appropriate. This supports the reading that the timing matters more than the iron itself.

Hougen I, Collister D, Bourrier M, et al. Safety of intravenous iron in dialysis: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2018;13(3):457-467. [Review, RCT and observational, n>130,000] DOI: 10.2215/CJN.05390517

A particularly vulnerable group was also studied: severely ill people in intensive care, where infections are a central issue anyway. If intravenous iron clearly encouraged infections, this is exactly where it should show.

Meta-analysis · 8 RCT · n=1,198 Intensive care patients and infection

Who and what: A systematic review with meta-analysis evaluated eight randomised trials with about 1,200 critically ill adults and examined the efficacy and safety of intravenous iron, including infections and mortality.

What they observed: For infections there was no effect in either direction, though on the basis of a rather uncertain data set. Mortality was not increased in the direct comparison either.

What this means for you: Even in a high-risk group, no clear infection signal emerged. The authors stress at the same time that larger, carefully designed studies are needed to answer the question conclusively.

Geneen LJ, Brunskill SJ, Doree C, et al. Efficacy and safety of intravenous iron therapy for treating anaemia in critically ill adults: a rapid systematic review with meta-analysis. Transfus Med Rev. 2022;36(2):97-106. [Meta-analysis, 8 RCT, n=1,198] DOI: 10.1016/j.tmrv.2021.12.002

The other half of the truth: deficiency is not harmless either

In all of this it is easy to lose sight of the fact that the equation less iron equals better protection does not hold. The immune system needs iron itself. Many defence cells depend on a sufficient supply in order to mature and to work.

A pronounced iron deficiency can therefore in turn impair immune function, alongside the better-known consequences such as fatigue and reduced performance. The aim is therefore not an extreme, but a balance. The body wants neither to see iron swimming freely in abundance in the blood, where pathogens could use it, nor to have to skimp permanently at every corner.

Review Deficiency as a risk in its own right

Who and what: A comprehensive review of iron deficiency describes the varied consequences of a deficiency and the role of hepcidin in regulating the iron balance, including under inflammatory conditions.

What this means for you: Iron is not a pure risk that is best avoided. It is a necessary building block whose lack creates problems of its own. The task is to set the status according to the need, not to keep it low across the board.

Pasricha SR, Tye-Din J, Muckenthaler MU, Swinkels DW. Iron deficiency. Lancet. 2021;397(10270):233-248. [Review] DOI: 10.1016/S0140-6736(20)32594-0

A look at the preparations also helps here. Part of the theoretical risk hangs on free iron, that is, unbound iron that can circulate briefly in the blood and is exactly what pathogens could use. Modern intravenous preparations are built so that they bind the iron more stably and release it more slowly. This produces less free iron than the old, high-molecular preparations. So part of the historical concern comes from a time when the preparations were different. We have described this development in more detail in the article on side effects of old and modern preparations.

Where caution is warranted

Unfavourable timing and context

  • Acute, feverish infection or one needing treatment
  • Dosing without a confirmed deficiency
  • Iron values not interpretable in the middle of an infection
  • Outdated preparation with more free iron
  • Repeated top-ups without follow-up checks
Where the signal stays small

Stable state, done correctly

  • No acute infection at the time of dosing
  • A genuine deficiency confirmed as a precondition
  • Modern preparation with stable binding
  • Dose matched to the measured gap
  • Monitoring and later follow-up checks

How it all fits together for you

If one thread runs through this topic, it is this: the iron-feeds-the-bugs hypothesis is not wrong, but it is incomplete. It describes very well what happens during an active infection, and it is exactly there that it leads to the right conclusion, namely caution. But it overestimates what a planned, controlled dose does in a stable person with a genuine deficiency.

The evidence is largely reassuring without being flawless. There is a small infection signal in the largest analysis, but there is no indication of more mortality or longer hospital stays, and other large works find no increased risk at all. To let this range stand honestly is more serious than to smooth over one side.

Science and experience kept separate

What the evidence supports: with a confirmed deficiency and a stable state, intravenous iron is not associated with a broadly increased infection risk, and a slight relative signal in one large analysis does not translate into mortality or length of hospital stay.

What I add in practice: from an integrative perspective I take care not to place an infusion into an acute infection, but to let the infection clear first, not least because the iron status can then be judged more reliably. This is clinical care that fits the existing evidence, and we deliberately name it as a matter of experience.

What you can do yourself is manageable. You do not need to read a meta-analysis to be well cared for. It is enough to ask a few questions that a careful treatment answers anyway.

Four questions about iron and infection

  • Is there an infection right now? If so, the infusion can usually be postponed until it has cleared.
  • Is my deficiency confirmed? Iron without a documented gap is not the means of choice.
  • Which preparation is used? Modern preparations release less free iron.
  • When will it be checked? A later follow-up measurement can help keep the status in view.

The most honest answer to the question whether iron feeds pathogens is: it is not the iron that is the problem, but the wrong timing. In the middle of an infection you wait, afterwards the situation is different.

At ViveCura in Berlin we see the iron balance as part of a larger picture. Our three focus areas, hormonal balance, mental health and metabolic health, are connected more closely than it first appears. An overlooked iron deficiency can show up in all three areas, from exhaustion to mood to everyday energy. And now you know why the question of iron and infection is never just a question about the iron, but always also one about the right moment to give it.

Frequently asked questions

Does an iron infusion raise the risk of infection?

Based on the available evidence, the answer is largely reassuring. The largest meta-analyses find no increased risk of serious complications or of mortality. A very large review of 154 randomised trials did, however, find a slightly raised relative risk of infection with intravenous iron, without any effect on mortality or length of hospital stay. The signal is therefore small, real and context-dependent. When a deficiency is confirmed, a modern preparation is used and the procedure is carried out correctly, the benefit usually outweighs it.

Does an iron infusion feed bacteria?

The concern has a kernel of truth. Many pathogens need iron to grow, and during an infection the body deliberately withholds iron from them, a mechanism known as nutritional immunity. In theory, additional iron could undermine this protection. In practice, though, this mechanism mainly comes into play when an infection is already active. In a stable state without an acute infection, the large studies show no broadly increased risk. That is precisely why an acute infection is a good reason to wait before giving iron.

Why should you not receive an iron infusion during an acute infection?

During an acute infection the body deliberately lowers the iron available in the blood to deprive pathogens of the nutrient. Through the hormone hepcidin, iron is held back in the stores. Adding iron through the vein in this phase works against the body's own protection. That is why an acute infection that needs treatment is considered a reason to postpone the infusion until the infection has cleared. This is not a weakness of the treatment, but part of what a properly performed infusion involves.

How large is the infection risk from intravenous iron really?

It is a slightly raised relative risk, not a frequent complication. In the largest review the relative risk was around 1.17, so roughly 17 percent above the comparison group, with moderate certainty of the evidence. Other large analyses found no increased risk at all. Importantly, neither mortality nor length of hospital stay was affected. This points to a small, usually clinically manageable signal that depends on the situation in which the iron is given.

Does iron deficiency itself weaken the immune system?

A deficiency is not harmless either. Iron is needed by many immune cells and for normal defence function. A pronounced iron deficiency can come with fatigue, reduced performance and impaired immune function. So the picture is not as simple as less iron equals better protection. Both too much at the wrong time and a lasting too little can disturb the balance. The aim is an iron status that matches the need, not as little and not as much as possible.

Does the infection risk also apply to modern iron preparations?

Part of the concern comes from older studies and older preparations. Modern intravenous iron preparations release the iron more slowly and more stably, so that less free, unbound iron circulates in the blood. Free iron is exactly what pathogens could use. No blanket guarantee can be drawn from this, but modern preparations can be viewed more favourably in this respect. What remains decisive is the timing of the dose and ruling out an acute infection.

Do dialysis patients get more infections from iron infusions?

Dialysis patients often receive intravenous iron regularly, which is why this group is particularly well studied. A review of randomised and observational studies with over 130,000 patients in total found no clearly increased infection risk for higher-dose intravenous iron compared with lower dosing. Mortality and hospital stays were not increased either. These data suggest that the infection signal stays limited even with frequent dosing, as long as the indication and dose are appropriate.

Should I wait with an iron infusion after recovering from an infection?

As a rule it makes sense to let an acute infection clear before a planned iron infusion is given. During the infection the iron values in the blood are altered anyway and hard to interpret, and the body deliberately holds iron back. Once it has cleared, the iron status can be assessed more reliably and the dose better managed. Exactly how long to wait depends on the type and severity of the infection and belongs in a conversation with your doctor.

Read on in the iron guide

SJ
Shukri Jarmoukli
Physician, Integrative Medicine · ViveCura Berlin
Skalitzer Straße 137, 10999 Berlin

Sources

  1. Shah AA, Donovan K, Seeley C, Dickson EA, Palmer AJR, Doree C, et al. Risk of infection associated with administration of intravenous iron: a systematic review and meta-analysis. JAMA Netw Open. 2021;4(11):e2133935. DOI: 10.1001/jamanetworkopen.2021.33935 [Meta-analysis, 154 RCT, n=32,920]
  2. Litton E, Xiao J, Ho KM. Safety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: systematic review and meta-analysis of randomised clinical trials. BMJ. 2013;347:f4822. DOI: 10.1136/bmj.f4822 [Meta-analysis, 72 RCT, n=10,605]
  3. Avni T, Bieber A, Grossman A, Green H, Leibovici L, Gafter-Gvili A. The safety of intravenous iron preparations: systematic review and meta-analysis. Mayo Clin Proc. 2015;90(1):12-23. DOI: 10.1016/j.mayocp.2014.10.007 [Meta-analysis, 103 RCT, n=10,390]
  4. Hougen I, Collister D, Bourrier M, Ferguson T, Hochheim L, Komenda P, et al. Safety of intravenous iron in dialysis: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2018;13(3):457-467. DOI: 10.2215/CJN.05390517 [Review, RCT and observational, n>130,000]
  5. Geneen LJ, Brunskill SJ, Doree C, Estcourt LJ, Roberts DJ. Efficacy and safety of intravenous iron therapy for treating anaemia in critically ill adults: a rapid systematic review with meta-analysis. Transfus Med Rev. 2022;36(2):97-106. DOI: 10.1016/j.tmrv.2021.12.002 [Meta-analysis, 8 RCT, n=1,198]
  6. Nairz M, Weiss G. Iron and innate antimicrobial immunity: Depriving the pathogen, defending the host. J Trace Elem Med Biol 2018;48:118-133. DOI: 10.1016/j.jtemb.2018.03.007 [Mechanism review]
  7. Ganz T. Iron in innate immunity: starve the invaders. Curr Opin Immunol. 2009;21(1):63-67. DOI: 10.1016/j.coi.2009.01.011 [Mechanism review]
  8. Pasricha SR, Tye-Din J, Muckenthaler MU, Swinkels DW. Iron deficiency. Lancet. 2021;397(10270):233-248. DOI: 10.1016/S0140-6736(20)32594-0 [Review]

This article summarises the scientific literature (researched via PubMed) and serves for general information. It does not replace medical advice, diagnosis or treatment. Whether an iron infusion is sensible and safe for you, which timing fits and whether an acute infection or other contraindications are present can only be clarified individually and in a conversation with your doctor.

Have questions or want to book an appointment?

We'd be happy to advise you personally at our practice.

Book appointment